Autonomously growing implantable device

Patent metadata

Field	Value
Publication number	US-10905795-B2
Application number	US-201716077787-A
Country	US
Kind code	B2
Filing date	Feb 16, 2017
Priority date	Feb 16, 2016
Publication date	Feb 2, 2021
Grant date	Feb 2, 2021

Abstract

An implantable, autonomously growing medical device is disclosed. The device may have an outer, braided outer element that holds an inner core. Degradation and/or softening of the inner core permits the outer element to elongate, allowing the device to grow with surrounding tissue. The growth profile of the medical device can be controlled by altering the shape/material/cure conditions of the inner core, as well as the geometry of the outer element.

First claim

The invention claimed is:

1. An implantable device, comprising:
an outer element having a first length; and
an inner core disposed within the outer element, wherein presence of the inner core limits elongation of the outer element,
wherein degradation of the inner core permits elongation of the outer element from the first length to a second length that is longer than the first length.

2. The implantable device of claim 1 , wherein the inner core comprises a polymer.

3. The implantable device of claim 1 , wherein the inner core comprises a biodegradable core.

4. The implantable device of claim 1 , wherein the inner core comprises a material that softens over time when placed in contact with body fluids.

5. The implantable device of claim 1 , wherein the inner core comprises an erodible metal.

6. The implantable device of claim 1 , wherein the outer element comprises a tubular sleeve.

7. The implantable device of claim 6 , wherein the outer element comprises a biaxially braided element.

8. The implantable device of claim 1 , wherein the outer element comprises a braided element.

9. The implantable device of claim 8 , wherein the outer element has a pitch of 20 to 70 picks per inch.

10. The implantable device of claim 1 , wherein the second length is 10 to 180 percent greater than the first length.

11. The implantable device of claim 1 , wherein the outer element is made of ultra-high-molecular-weight polyethylene.

12. The implantable device of claim 1 , wherein the outer element is made of polytetrafluoroethylene.

13. The implantable device of claim 1 , wherein degradation of the inner core permits the outer element to grow in two dimensions.

14. The implantable device of claim 1 , wherein the inner core comprises a plurality of separate pieces.

15. The implantable device of claim 14 , wherein the plurality of pieces are spaced from one another.

16. The implantable device of claim 1 , wherein the inner core is formed as a single piece.

17. The implantable device of claim 1 , wherein the inner core has a curved shape.

18. The implantable device of claim 1 , wherein the inner core is made of a modified form of poly(glycerol sebacate) that is formed by curing a poly(glycerol sebacate) pre-polymer at a temperature of over 150° C. for over 80 hours.

19. The implantable device of claim 18 , wherein the poly(glycerol sebacate) pre-polymer is cured at a temperature of 155° C. for 86 hours.

20. The implantable device of claim 1 , wherein the inner core is a degradable elastomer.

21. The implantable device of claim 20 , wherein the degradable elastomer is poly(glycerol sebacate).

22. The implantable device of claim 20 , wherein the degradable elastomer has a Young's Modulus that is greater than 5 MPa.

23. The implantable device of claim 1 , wherein an instantaneous length L of the outer element is defined by the following equation:
L ( D )=√{square root over ((π nD i ) 2 +L i 2 −(π nD ) 2 )}

wherein n is braid pitch as defined by number of fiber turns per unit length, D i is initial element diameter, L i is initial element length, and D is instantaneous element diameter.

24. The implantable device of claim 1 , wherein the inner core comprises a biodegradable polymer comprising:
a Young's Modulus of greater than 5 MPa; and
a crosslinking density of 600 to 12,000 mols per cubic meter,
wherein the polymer is formed from curing a poly(glycerol sebacate) pre-polymer in vacuum at a temperature of 140° C. to 160° C. for 40 to 100 hours.

25. A method of forming the polymer of the implantable device of claim 24 , the method comprising:
polycondensation of an equimolar ratio of glycerol and sebacic acid at 120° C. for 8 hours under dry nitrogen and for 16 hours in vacuum to form a pre-polymer; and
curing the pre-polymer in a vacuum at a temperature of 140° C. to 160° C. for 40 to 100 hours.

26. The implantable device of claim 1 , wherein the inner core has a cylindrical shape.

27. A method of using an implantable device, comprising:
providing an outer element with an inner core disposed within the outer element; and
coupling the outer element to an implantation site,
wherein:
contacting the inner core with body fluid at the implantation site initiates degradation or softening of the inner core,
degradation of the inner core permits elongation of the outer element from a first length to a second length that is longer than the first length, and
the length of the outer element changes from the first length to the second length in response to degradation of the inner core and to forces from native growing tissue at the implantation site acting on the outer element.

Assignees

• Childrens Medical Center
• Brigham & Womens Hospital Inc

Inventors

• Feins Eric N
• Del Nido Pedro J
• Vasilyev Nikolay V
• Yamauchi Haruo
• Perrin Douglas P
• Hammer Peter
• Arabagi Veaceslav
• Karp Jeffrey M
• Lee Yuhan
• O'Cearbhaill Eoin D

Classifications

• A61F2/2445

  Annuloplasty rings in direct contact with the valve annulus · CPC title

• A61F2002/2892

  Tibia · CPC title

• A61F2002/30706

  specially designed for children, e.g. having means for adjusting to their growth · CPC title

• A61L27/18

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

• A61L27/16 Primary

  obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title